UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

H19 locus acts in vivo as a tumor suppressor

Proceedings of the National Academy of Sciences - PNAS, 2008-08, Vol.105 (34), p.12417-12422

2008

Volltextzugriff (PDF)

APC is required for muscle stem cell proliferation and skeletal muscle tissue repair

The Journal of cell biology, 2015-08, Vol.210 (5), p.717-726

2015

Volltextzugriff (PDF)

ARID2 Chromatin Remodeler in Hepatocellular Carcinoma

Cells (Basel, Switzerland), 2020-09, Vol.9 (10), p.2152

2020

Volltextzugriff (PDF)

Wnt, glucocorticoid and cellular prion protein cooperate to drive a mesenchymal phenotype with poor prognosis in colon cancer

Journal of translational medicine, 2024-04, Vol.22 (1), p.337-337, Article 337

2024

Volltextzugriff (PDF)

Focusing on beta‐catenin activating mutations to refine liver tumor profiling

Hepatology (Baltimore, Md.), 2016-12, Vol.64 (6), p.1850-1852

Colnot, Sabine

2016

Volltextzugriff (PDF)

Crypt-restricted proliferation and commitment to the Paneth cell lineage following Apc loss in the mouse intestine

Development (Cambridge), 2005-03, Vol.132 (6), p.1443-1451

2005

Volltextzugriff (PDF)

ARID1A loss in adult hepatocytes activates β-catenin-mediated erythropoietin transcription

eLife, 2020-10, Vol.9

2020

Volltextzugriff (PDF)

Generation of Mice with Hepatocyte-Specific Conditional Deletion of Notum

PloS one, 2016-03, Vol.11 (3), p.e0150997-e0150997

2016

Volltextzugriff (PDF)

Identification of the IFITM family as a new molecular marker in human colorectal tumors

Cancer research (Chicago, Ill.), 2006-02, Vol.66 (4), p.1949-1955

2006

Volltextzugriff (PDF)

LKB1 and Notch Pathways Interact and Control Biliary Morphogenesis

PloS one, 2015-12, Vol.10 (12), p.e0145400-e0145400

2015

Volltextzugriff (PDF)

Tumor promotion and inhibition by phenobarbital in livers of conditional Apc-deficient mice

Archives of toxicology, 2016-06, Vol.90 (6), p.1481-1494

2016

Volltextzugriff (PDF)

Colorectal cancers in a new mouse model of familial adenomatous polyposis: influence of genetic and environmental modifiers

Laboratory investigation, 2004-12, Vol.84 (12), p.1619-1630

2004

Volltextzugriff (PDF)

Antagonism between wild-type and mutant β-catenin controls hepatoblastoma differentiation via fascin-1

JHEP reports, 2023-05, Vol.5 (5), p.100691-100691, Article 100691

2023

Volltextzugriff (PDF)

A Complex Interplay between Wnt/β-Catenin Signalling and the Cell Cycle in the Adult Liver

International journal of hepatology (New York), 2012-01, Vol.2012, p.816125-7

2012

Volltextzugriff (PDF)

Maternal obesity: A severe risk factor in hepatocarcinogenesis?

Journal of hepatology, 2020-09, Vol.73 (3), p.502-504

2020

Volltextzugriff (PDF)

Glutamine metabolism, a double agent combating or fuelling hepatocellular carcinomaKey points

JHEP reports, 2024-05, Vol.6 (5), p.101077

2024

Volltextzugriff (PDF)

OS-023-YI - Remodeling of myeloid cells during hepatocellular carcinoma driven by beta-catenin activation

Journal of hepatology, 2023-06, Vol.78, p.S29-S29

2023

Volltextzugriff (PDF)

Remodeling of myeloid cells during hepatocellular carcinoma driven by beta-catenin activation

Journal of hepatology, 2023-06, Vol.78, p.S29

2023

Volltextzugriff (PDF)

Une imagerie métabolique des cancers primitifs du foie fondée sur leur addiction à la choline prédit leur oncogénotype et ouvre une piste thérapeutique

M.S. Médecine sciences, 2020-04, Vol.36 (4), p.322-326

2020

Volltextzugriff (PDF)

Transcription dynamics in a physiological process: β-Catenin signaling directs liver metabolic zonation

The international journal of biochemistry & cell biology, 2011-02, Vol.43 (2), p.271-278

2011

Volltextzugriff (PDF)

Deficiency of the LIM-only protein FHL2 reduces intestinal tumorigenesis in Apc mutant mice

PloS one, 2010-04, Vol.5 (4), p.e10371

2010

Volltextzugriff (PDF)

β-catenin-activated hepatocellular carcinomas are addicted to fatty acids

Gut, 2019-02, Vol.68 (2), p.322-334

2019

Volltextzugriff (PDF)

FRI-465 The fetal insulin receptor isoform stimulates liver carcinogenesis through non-cell autonomous mechanisms

Journal of hepatology, 2024-06, Vol.80, p.S416-S417

2024

Volltextzugriff (PDF)

Deleting the β-catenin degradation domain in mouse hepatocytes drives hepatocellular carcinoma or hepatoblastoma-like tumor growth

Journal of hepatology, 2022-08, Vol.77 (2), p.424-435

2022

Volltextzugriff (PDF)

Glutamine metabolism, a double agent combating or fuelling hepatocellular carcinoma

JHEP reports, 2024-05, Vol.6 (5), p.101077-101077, Article 101077

2024

Volltextzugriff (PDF)

1 – 25 von 80

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(71)

Publikationsform

Artikel
(79)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Hepatology
(8)
M.S. Médecine Sciences
(8)
Gut
(7)
Hepatology
(5)
Plos One
(4)
Elife
(3)
Gastroenterology
(3)
Jhep Reports
(3)
The Journal Of Biological Chemistry
(3)
Clinics And Research In Hepatology And Gastroenterology
(2)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

H19 locus acts in vivo as a tumor suppressor

APC is required for muscle stem cell proliferation and skeletal muscle tissue repair

ARID2 Chromatin Remodeler in Hepatocellular Carcinoma

Wnt, glucocorticoid and cellular prion protein cooperate to drive a mesenchymal phenotype with poor prognosis in colon cancer

Focusing on beta‐catenin activating mutations to refine liver tumor profiling

Crypt-restricted proliferation and commitment to the Paneth cell lineage following Apc loss in the mouse intestine

ARID1A loss in adult hepatocytes activates β-catenin-mediated erythropoietin transcription

Generation of Mice with Hepatocyte-Specific Conditional Deletion of Notum

Identification of the IFITM family as a new molecular marker in human colorectal tumors

LKB1 and Notch Pathways Interact and Control Biliary Morphogenesis

Tumor promotion and inhibition by phenobarbital in livers of conditional Apc-deficient mice

Colorectal cancers in a new mouse model of familial adenomatous polyposis: influence of genetic and environmental modifiers

Antagonism between wild-type and mutant β-catenin controls hepatoblastoma differentiation via fascin-1

A Complex Interplay between Wnt/β-Catenin Signalling and the Cell Cycle in the Adult Liver

Maternal obesity: A severe risk factor in hepatocarcinogenesis?

Glutamine metabolism, a double agent combating or fuelling hepatocellular carcinomaKey points

OS-023-YI - Remodeling of myeloid cells during hepatocellular carcinoma driven by beta-catenin activation

Remodeling of myeloid cells during hepatocellular carcinoma driven by beta-catenin activation

Une imagerie métabolique des cancers primitifs du foie fondée sur leur addiction à la choline prédit leur oncogénotype et ouvre une piste thérapeutique

Transcription dynamics in a physiological process: β-Catenin signaling directs liver metabolic zonation

Deficiency of the LIM-only protein FHL2 reduces intestinal tumorigenesis in Apc mutant mice

β-catenin-activated hepatocellular carcinomas are addicted to fatty acids

FRI-465 The fetal insulin receptor isoform stimulates liver carcinogenesis through non-cell autonomous mechanisms

Deleting the β-catenin degradation domain in mouse hepatocytes drives hepatocellular carcinoma or hepatoblastoma-like tumor growth

Glutamine metabolism, a double agent combating or fuelling hepatocellular carcinoma

Suchergebnisse filtern